帕金森病患者黑质中的铁 - Suppr

Suppr

超能文献

Iron in the Parkinsonian substantia nigra.

作者信息

Gerlach M, Double K, Riederer P, Hirsch E, Jellinger K, Jenner P, Trautwein A, Youdim M B

出版信息

Mov Disord. 1997 Mar;12(2):258-60.

PMID:9087993

Abstract

摘要

相似文献

Iron in the Parkinsonian substantia nigra.

Mov Disord. 1997 Mar;12(2):258-60.

Iron in parkinsonian and control substantia nigra--a Mössbauer spectroscopy study.

Mov Disord. 1996 Jan;11(1):8-16. doi: 10.1002/mds.870110104.

[Mossbauer spectroscopy of iron in substantia nigra in Parkinson disease and controls].

Neurol Neurochir Pol. 1994;28(1 Suppl 1):145-55.

Iron and ferritin in substantia nigra in Parkinson's disease.

Adv Neurol. 1993;60:267-72.

Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.

Neuroreport. 2006 Jul 31;17(11):1215-8. doi: 10.1097/01.wnr.0000227984.84927.a7.

Iron and reactive oxygen species activity in parkinsonian substantia nigra.

Parkinsonism Relat Disord. 2010 Jun;16(5):329-33. doi: 10.1016/j.parkreldis.2010.02.007. Epub 2010 Mar 9.

The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.

Adv Neurol. 1990;53:31-4.

Is iron involved in pathogenesis of Parkinson's disease--Mössbauer spectroscopy study of substantia nigra in control and disease brains.

Neurol Neurochir Pol. 1996;30 Suppl 2:95-103.

Diagnostic evaluation of the substantia nigra.

Neuropathol Appl Neurobiol. 1996 Jun;22(3):228-32.

What is the advantage of having melanin in parts of the central nervous system (e.g. substantia nigra)?

IUBMB Life. 2004 Jan;56(1):47-9. doi: 10.1080/15216540310001659029.

引用本文的文献

Overdosing on iron: Elevated iron and degenerative brain disorders.

Exp Biol Med (Maywood). 2020 Oct;245(16):1444-1473. doi: 10.1177/1535370220953065. Epub 2020 Sep 2.

The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia.

J Neural Transm (Vienna). 2020 Feb;127(2):159-168. doi: 10.1007/s00702-019-02120-x. Epub 2019 Dec 17.

Mitochondrial aconitase knockdown attenuates paraquat-induced dopaminergic cell death via decreased cellular metabolism and release of iron and H₂O₂.

J Neurochem. 2011 Jul;118(1):79-92. doi: 10.1111/j.1471-4159.2011.07290.x. Epub 2011 May 19.

Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.

Brain Res. 2009 Nov 10;1297:17-22. doi: 10.1016/j.brainres.2009.08.043. Epub 2009 Aug 21.

Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals.

Synapse. 2009 Dec;63(12):1133-42. doi: 10.1002/syn.20686.

Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.

Neurotox Res. 2003;5(1-2):1-26. doi: 10.1007/BF03033369.

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Drugs Aging. 1999 Feb;14(2):115-40. doi: 10.2165/00002512-199914020-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验